Document Detail


Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity.
MedLine Citation:
PMID:  3123539     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ten children with challenge-proven egg hypersensitivity and atopic dermatitis were enrolled in a double-blind crossover trial of oral cromolyn sodium. After receiving up to 40 mg/kg/day of cromolyn or placebo for 1 week, patients underwent double-blind placebo-controlled oral food challenges. In the eight subjects who reacted to the food challenge, there was no significant difference in the amount of food allergen eliciting the positive response, the timing of onset until first subjective or objective symptoms developed, symptoms provoked, or the duration of the symptoms in either phase of the study. This study demonstrates no benefit in the treatment of children with atopic dermatitis and food hypersensitivity with oral cromolyn sodium.
Authors:
A W Burks; H A Sampson
Related Documents :
10165109 - Ptosis evaluation and management in the 21st century.
3278199 - The reliability and validity of provocative food testing: a critical review.
8755979 - Responses of dogs with food allergies to single-ingredient dietary provocation.
12390099 - Gut mucosal response to food antigens in crohn's disease.
17581199 - The changing face of food hypersensitivity in an asian community.
7848179 - Diagnosis and management of food allergy and intolerance in dogs and cats.
8137319 - Potential of food modification in cancer prevention.
17269139 - Discrete crosslinked fibrin microthread scaffolds for tissue regeneration.
15927729 - Children eat what they are served: the imprecise regulation of energy intake.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of allergy and clinical immunology     Volume:  81     ISSN:  0091-6749     ISO Abbreviation:  J. Allergy Clin. Immunol.     Publication Date:  1988 Feb 
Date Detail:
Created Date:  1988-03-21     Completed Date:  1988-03-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1275002     Medline TA:  J Allergy Clin Immunol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  417-23     Citation Subset:  AIM; IM    
Affiliation:
University of Arkansas, Fayetteville.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Allergens / administration & dosage
Child
Child, Preschool
Clinical Trials as Topic* / methods
Cromolyn Sodium / administration & dosage*
Dermatitis, Atopic / complications,  drug therapy*
Double-Blind Method
Eggs / adverse effects
Female
Food Hypersensitivity / complications,  drug therapy*
Humans
Male
Placebos
Grant Support
ID/Acronym/Agency:
AI24439/AI/NIAID NIH HHS; RR-30/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Allergens; 0/Placebos; 15826-37-6/Cromolyn Sodium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cognitive and behavioral findings in children taking theophylline.
Next Document:  Double-blind evaluation of nebulized cromolyn, terbutaline, and the combination for childhood asthma...